Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. - Wikidata - wikimedia - TriplyDB

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

http://www.wikidata.org/entity/Q37066731

about

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study Recent advances in understanding/management of non-alcoholic steatohepatitis.Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis--a comparison with routine biochemical markers Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Inflammation in nonalcoholic steatohepatitis.Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients Nonalcoholic fatty liver disease: Diagnostic biomarkers.Fatty liver disease in children: eat now pay later.Autophagy and non-alcoholic fatty liver disease.Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.An apoptosis panel for nonalcoholic steatohepatitis diagnosis Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.Diagnosis and evaluation of nonalcoholic fatty liver disease.Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis Cell death and cell death responses in liver disease: mechanisms and clinical relevance The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Nonalcoholic steatohepatitis: risk factors and diagnosis.Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.Clinical considerations for the management of residual diabetes following bariatric surgery.The epidemiology, pathogenesis and histopathology of fatty liver disease.Nonalcoholic fatty liver disease: current issues and novel treatment approaches.Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease.Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis.Apoptosis and diagnosis of nonalcoholic steatohepatitis.Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?

P2860

Q24657221-3A077F19-B66C-49E9-84DF-D888D0CB4F91 Q28085689-F38A7ECA-A23F-47AB-BD59-A110B421B4E2 Q28542723-42219DBE-13FD-4D45-9489-331E6197F295 Q30432576-8CFFFCEC-0A6C-4A32-9EC9-7794C233DA29 Q30453231-7D597172-403B-41F5-9228-D37040F4165E Q30464608-C62E2545-2223-4B86-8179-D8334C11CF24 Q33637279-983AF49A-65E7-4540-950E-341A29D40DD4 Q33706254-CB3CF416-C0C0-402A-8325-FBEB22B0436D Q33718945-0A63D6DC-FA72-4E77-977A-CB4D711D89EC Q34247340-0D1B4DE3-2951-4479-9C91-5B122BF87979 Q34698815-F05B852C-BC97-4995-80B1-43EF93321F5C Q34802423-45420532-BC45-4445-8D41-49CE00CD08A8 Q34830398-992BB032-F35A-4B54-87BC-02194D57434C Q34995562-A2D2145D-0506-4DD4-BA12-89FFBCF80675 Q35064093-00D530B1-CD7E-4E16-8C42-E8D0FCE7B54D Q35101419-4C556BA6-6AA3-4D42-957A-DB48B4D344A4 Q35495753-A7F78046-3FBA-49DA-B949-FC54B34202B5 Q35674098-E24B92AF-D40B-4529-8D0F-29A61C84ECB1 Q35938040-B808A127-7D26-4762-B3FA-A28F46DA1273 Q35963873-26BE8A3E-482D-4E78-954E-DE5A89F23B82 Q36328050-5256F332-9FF9-46CB-85B7-7983B7A90D05 Q36495366-65359AD3-935F-429C-B2F8-186CA10BEBCF Q36782785-248954A7-E163-453E-B00F-679F9AD1D87D Q37189403-052CBBEC-34BD-4CD6-8F7C-E3763DF19A78 Q37689828-734D2739-8A83-4F2C-91B6-D5A41D911E2D Q37798824-1FA72DB3-73CA-4D25-88E1-BE8FD9BED506 Q37811071-1FC147DF-E481-4ED8-8D0F-F9D6A92437F4 Q37863133-F0B5741A-3E9B-4CBB-8B47-E37BD7834329 Q37979850-6F23108B-D696-44D7-B669-461AEB305198 Q37988893-AEFD95FC-0841-4227-840D-39ACEC875037 Q38074898-37F6D307-BC26-4230-B9A4-CE86C57B776C Q38494198-BBADC767-D1B9-47E5-ADB4-343149B4CBB4 Q38720197-4CBEDE05-C43D-4289-B60A-CFAA00B84817 Q38725581-4EED1391-B306-42AB-8851-1679CF677D4D Q38790052-12203973-6198-4157-98C2-51A5FC70EA86 Q38974249-45205A71-16FE-48E4-9A95-901C5BC150F5 Q39096520-5C81E79B-405E-40BB-AAE5-554B6C59C9C9 Q39109576-6A8F77BC-69A2-451A-B81C-46CB7D3D2D9F Q42180658-589FEABB-7283-4725-AD31-5B39A695BE4A Q43092106-AD3A076A-B764-4CE3-AD05-953233989A13

P2860

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.

http://www.wikidata.org/entity/Q37066731

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@en

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@nl

type

label

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@en

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@nl

prefLabel

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@en

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@nl

P1433

Q37066731-3E90D88A-34BF-4DB4-AF3C-523CE896189C

P1476

Q37066731-35608E32-EF88-4D8A-A6F0-B86E70B9907F

P2093

Q37066731-14ACDA4A-20E8-43A9-8D4B-0984D72C88DA

Q37066731-201797A7-8BE8-469F-AF5C-88D2480B3897

Q37066731-35C9C073-4CEC-45EF-9E8A-A2A535724D86

Q37066731-59D8950C-84CC-4773-A1C0-5E85B19971C0

Q37066731-720AD461-1FA1-4A63-BD17-FDD8FC29ACC3

Q37066731-AA8010F1-CD60-48D5-B639-63EDEAE650D3

Q37066731-ACCC6C2E-8780-4666-81D8-D24CD982A1DD

P2860

Q37066731-0CA751AC-15A7-459B-B89D-5E8286580F6D

Q37066731-16AAD1CB-2358-4988-A605-A43EE41A7B94

Q37066731-3D1CC233-FA1B-4244-9417-85D66009BBB3

Q37066731-540F63E6-8437-45B1-B095-4F7F4DD2E5BB

Q37066731-5AEF8CC5-B5E2-4953-87ED-0A165BDD164B

Q37066731-6FB3EA9A-74A6-4006-B4C5-E245E7D2BBD9

Q37066731-71A3E1EC-413C-4BEC-9B84-9D72F68B715C

Q37066731-78FC500E-1CB7-450B-927A-0F2EE658FD0D

Q37066731-84B35226-D10C-4F5C-8DAE-29A0FB8D256E

Q37066731-93A70EC3-4D34-476E-B077-FE4738B01D20

P304

Q37066731-6C0EAF84-1140-4CA7-9053-CE14854C5A0B

P31

Q37066731-68D36E52-A628-4421-B42F-4BD4BA06CBD5

P356

Q37066731-7B8C5880-4B97-40C4-AFD7-296F9904C6BD

P407

Q37066731-97DE24FE-141E-4236-86BC-7432AF266465

P433

Q37066731-9384483B-9F39-4760-82AD-B39D205DB3E4

P478

Q37066731-0F8A336E-FBA5-49A2-9863-A1A809BA1241

P577

Q37066731-B6481EDD-6798-48AD-B4ED-4F23EB3D0A2E

P5875

Q37066731-94BED27D-C296-404D-9293-24FE44FCF08E

P698

Q37066731-3C7E6B4D-6F5F-4A09-8B14-9C3480DC5D8D

P921

Q37066731-482DB347-5541-4982-8300-C4204B320E03

Q37066731-7AB2EB3A-12C8-4066-9FCA-A32037D76FFA

Q37066731-9496A6FA-3516-4AE6-9917-727C45A4EEF1

Q37066731-F1B02BE1-41EE-45CC-B668-7CBF12221AF9

P932

Q37066731-263CE39B-1D22-46D7-ABCD-4CB32EF8A52E

P356

J.CGH.2008.07.016

P1433

Clinical Gastroenterology and Hepatology

P1476

Cytokeratin 18 fragment levels ...... in bariatric surgery patients.

@en

P2093

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Dima L Diab

http://www.w3.org/2001/XMLSchema#string

Lisa Yerian

http://www.w3.org/2001/XMLSchema#string

Philip Schauer

http://www.w3.org/2001/XMLSchema#string

Rocio Lopez

http://www.w3.org/2001/XMLSchema#string

Sangeeta R Kashyap

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

P2860

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Results of laparoscopic gastric bypass in patients with cirrhosis.

Nonalcoholic fatty liver disease in individuals with severe obesity.

Nonalcoholic fatty liver disease and the epidemic of obesity.

Pathological features of NASH.

Apoptosis in alcoholic and nonalcoholic steatohepatitis.

P304

1249-1254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CGH.2008.07.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23460338

http://www.w3.org/2001/XMLSchema#string

P698

18995215

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

bariatric surgery

P932

2628560

http://www.w3.org/2001/XMLSchema#string